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Background: Bovine enterotoxemia is a major cause of mortality in veal calves. Predominantly veal calves of beef
cattle breeds are affected and losses due to enterotoxemia may account for up to 20% of total mortality.
Clostridium perfringens type A is considered to be the causative agent. Recently, alpha toxin and perfringolysin O
have been proposed to play an essential role in the development of disease. However, other potential virulence
factors also may play a role in the pathogenesis of bovine enterotoxemia. The aim of this study was to evaluate
whether strains originating from bovine enterotoxemia cases were superior in in vitro production of virulence
factors (alpha toxin, perfringolysin O, mucinase, collagenase) that are potentially involved in enterotoxemia. To
approach this, a collection of strains originating from enterotoxemia cases was compared to bovine strains isolated
from healthy animals and to strains isolated from other animal species.
Results: Strains originating from bovine enterotoxemia cases produced variable levels of alpha toxin and
perfringolysin O that were not significantly different from levels produced by strains isolated from healthy calves
and other animal species. All tested strains exhibited similar mucinolytic activity independent of the isolation
source. A high variability in collagenase activity between strains could be observed, and no higher collagenase
levels were produced in vitro by strains isolated from enterotoxemia cases.
Conclusions: Bovine enterotoxemia strains do not produce higher levels of alpha toxin, perfringolysin O, mucinase
and collagenase, as compared to strains derived from healthy calves and other animal species in vitro.Background
Bovine enterotoxemia caused by Clostridium perfringens,
is a sudden death syndrome with necro-hemorrhagic
lesions in the small intestine, which mainly affects suck-
ling calves and veal calves [1,2]. In veal calves, predomin-
antly beef cattle breeds are affected. The syndrome
accounts for approximately 20% of the mortalities in these
calves, compared to 4% in dairy and mixed breed veal
calves [2,3]. Clostridium perfringens is an anaerobic gram-
positive spore-forming bacterium, which is a commensal* Correspondence: filip.vanimmerseel@ugent.be
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stated.of the gastrointestinal tract of both humans and animals,
and is also ubiquitous in soil and sewage [2,4,5]. Strains of
C. perfringens are classified into five toxinotypes (A-E)
based on the presence of four major toxin genes (alpha,
beta, iota and epsilon) [6]. Mainly strains of type A are re-
covered from enterotoxemia cases but also from the intes-
tine of healthy cattle and other warm-blooded animals as
well as from the environment [6]. C. perfringens type A
has the ability to produce numerous extracellular toxins
and enzymes, of which alpha toxin is the most toxic [7].
Recently alpha toxin, a phospholipase C, and perfringolysin
O, a pore forming cytolysin, have been proposed as essen-
tial factors for induction of enterotoxemia [8]. In addition
to these toxins, other potential virulence factors might have
a role in the pathology of enterotoxemia. Possible virulenceral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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mucus layer and extracellular matrix components or intra-
species inhibitory antibacterial substances that confer a se-
lective advantage to the producing strain, as suggested for
necrotic enteritis strains in broilers [9].
It is hitherto unclear whether the C. perfringens type A
strains isolated from enterotoxemia cases are more viru-
lent than other type A strains. In a calf intestinal loop
model, it has been shown that C. perfringens strains iso-
lated from healthy and enterotoxemic cattle as well as
from other host species are all capable of inducing necro-
hemorrhagic intestinal lesions [10].
The purpose of this study was to analyze the expression
of virulence factors that are potentially involved in entero-
toxemia. To approach this, the alpha toxin and perfringo-
lysin O production, the mucinolytic and gelatinolytic
activity as well as the intra-species inhibitory activity of a
collection of strains originating from enterotoxemia cases
was compared to bovine strains isolated from healthy ani-
mals and to strains isolated from other animal species.
Results
Clostridium perfringens strains from enterotoxemia cases are
not superior alpha toxin and perfringolysin O producers
To determine whether alpha toxin and perfringolysin O
levels differ between bovine enterotoxemia strains and
strains from other sources, the culture supernatants of
various type A strains were tested (Figure 1A). Lecithin
breakdown was used as a measure of alpha toxin activity.
The supernatants of the different strains showed high vari-
ability in alpha toxin activity, independent of their origin.
In eight strains, the alpha toxin activity was below the de-
tection limit of 15.6 10-3 U/ml (three strains originating
from enterotoxemia cases and five strains from healthy
calves). Perfringolysin O activity was determined by mea-
suring the hemolysis of horse erythrocytes. Supernatants
of strains originating from bovine enterotoxemia cases
showed a high variability in hemolytic activity. The mean
erythrocyte hydrolysis by strains from bovine enterotox-
emia was not significantly different from other strains, in-
dependent of the origin (Figure 1B). For both alpha toxin
and perfringolysin O, no significant differences between
enterotoxemia strains and other C. perfringens strains
could be observed.
Mucinolytic and gelatinolytic activity is not higher in
Clostridium perfringens strains from bovine
enterotoxemia cases
The thickness of the mucin layer reflects an equilibrium
between synthesis by the host and bacterial degradation
by the intestinal microbiota. We tested the mucinolytic
activity of C. perfringens strains from enterotoxemia cases
and from other sources to evaluate whether enterotoxemia
strains have higher potential to degrade the protectivemucus layer. All strains exhibited similar mucinolytic ac-
tivity (Figure 1C). To elucidate whether C. perfringens pro-
teases might have the potential to contribute to the
pathology of enterotoxemia, gelatinolytic activity was in-
vestigated as a measure for degrading extracellular matrix
components within the gut. Gelatin was used as a specific
proteolytic substrate to screen for clostridial protease ac-
tivity that might contribute to intestinal host matrix deg-
radation. A high variability of gelatinolytic activity was
seen. The mean gelatin breakdown by strains from bovine
enterotoxemia was not different from other strains, inde-
pendent of the origin (Figure 1D). No significant difference
between the groups could be observed.
Enterotoxemia strains have no increased intra-species
growth-inhibitory activity
The intra-species growth-inhibitory activity is shown in
Figure 2. Of all tested strains, sixty-one percent was able
to inhibit growth of at least one other C. perfringens strain.
There was a lot of variation between the inhibitory spectra
of the tested strains. Some strains inhibited only a limited
number of strains, while others had a broad inhibitory
spectrum. Five out of eight enterotoxemia strains, eight
out of twenty-three strains from healthy calves, four out
of five ruminating bovine strains and one out of five sheep
strains were unable to inhibit growth of any other strain.
No significant differences between the groups could be
observed.
Discussion
Clostridium perfringens type A strains isolated from bo-
vine enterotoxemia cases showed no difference in in vitro
expression of a selection of potential virulence factors
compared to strains from healthy cattle as well as various
other animal species. This is in accordance with the cap-
acity of lesion induction in a calf intestinal loop model, in
which all tested strains are capable of inducing necro-
hemorrhagic intestinal lesions, independent of the origin
of the isolate [10].
No increased activity of the alpha toxin and perfringo-
lysin O was detected in bovine enterotoxemia strains. In
a recent study carried out with alpha toxin and perfrin-
golysin O mutants we demonstrated an essential role of
both toxins in bovine enterotoxemia [8]. The alpha toxin
is the most toxic enzyme produced by C. perfringens type
A strains and hydrolyses two major constituents of the
eukaryotic membrane (phosphatidylcholine and sphingo-
myelin) causing membrane disruption and cell lysis [11,12].
In sublytic concentrations, alpha toxin leads to activa-
tion of signal transduction pathways and uncontrolled
production of intracellular mediators [12-14]. Perfringo-
lysin O is a pore-forming cytolysin which has the ability
to kill eukaryotic cells by punching holes in their mem-
branes [15]. As shown in vitro and in a calf intestinal loop
Figure 2 Intra-species growth-inhibition. Number of C.
perfringens strains (N = 46) inhibited by the individual strains
originating from bovine enterotoxemia cases, healthy calves,
ruminating cattle, sheep and chickens. The lines represent the mean
with the standard error of the means.
Figure 1 Quantification of putative virulence factor activities of C. perfringens strains derived from cattle, sheep and chickens. The lines
represent the mean with the standard error of the means. (A) The alpha toxin activity in the supernatant of anaerobically grown C. perfringens
strains was determined by measuring the lecithinase activity in an egg yolk agar well diffusion assay. (B) The perfringolysin O activity in the
supernatant of anaerobically grown C. perfringens strains was determined by measuring the hemolysis of horse erythrocytes. The PFO titer is the
reciprocal of the last dilution which showed complete hemolysis. Each difference in titer of one unit represents a twofold difference in perfringolysin O
activity. (C) The mucinolytic activity of C. perfringens strains was assayed by adding cultures of strains to wells in TSA-mucin plates and quantification of
zones of mucin lysis (in mm). (D) The potential to degrade the extracellular matrix was examined by measuring the breakdown of fluorescent labeled
gelatin by supernatant of anaerobically grown C. perfringens strains. RLU = relative light units.
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synergistic action in bovine enterotoxemia [8]. Consider-
ing this essential role of alpha toxin and perfringolysin O
in bovine enterotoxemia, C. perfringens type A strains with
higher activity of these toxins might be more virulent.
Despite the importance of alpha toxin and perfringolysin
O in enterotoxemia, strains originating from diseased ani-
mals showed no higher activities of these toxins in vitro.
No increased collagen degrading and mucinolytic po-
tential was detected in strains from enterotoxemia cases.
Collagen is widely distributed throughout the body and
is an integral component of the connective tissue. Colla-
gen disruption by bacterial collagenases may result in the
loss of tissue integrity and subsequent tissue necrosis in
the infected host and allow penetration of bacterial toxins
to deeper tissues [16]. Therefore, the ability to produce col-
lagenase may play an important role in the tissue destruc-
tion observed in bovine enterotoxemia. This in vitro study
showed no difference in collagen destroying potential be-
tween C. perfringens strains from bovine enterotoxemia
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chickens.
In addition to the collagen degradation, the mucinolytic
activity of the C. perfringens strains may also contribute to
the pathology of bovine enterotoxemia. The gastrointes-
tinal tract represents a large surface of the host that inter-
acts with the external world. A protective mucus layer
covers the epithelial surface, forming a barrier between
the lumen and the intestinal epithelium. It is a potential
binding site for both commensal and pathogenic organ-
isms [17,18]. C. perfringens type A strains with stronger
mucinolytic activity may have an advantage in colonizing
and degrading the protective mucus layer, which may lead
to a compromised barrier function. Enterotoxemia strains,
however were not different from the other strains with re-
spect to their mucinolytic activity in vitro.
Another possible virulence trait that was explored is
the ability to cause intra-species growth-inhibition. The
potential of a pathogenic strain to suppress the growth
of other C. perfringens strains has been shown in nec-
rotic enteritis in broiler chickens, leading to single clone
dominance in a broiler flock suffering from necrotic enter-
itis [9,19]. In contrast to the situation in broiler chickens,
our results showed no difference in intra-species growth-
inhibition between the enterotoxemia strains and other
C. perfringens strains. In addition, a clonal population of
C. perfringens does not seem to be essential for the de-
velopment of bovine enterotoxemia as seen by RAPD
(authors unpublished observations). Together this suggests
that intra-species growth-inhibition probably does not play
a role in the pathogenesis of bovine enterotoxemia.
None of the possible virulence traits examined in this
study were distinctive for C. perfringens type A strains
isolated from bovine enterotoxemia cases in vitro. This is
in accordance with a recent observation from our labora-
tory that, when the conditions are favorable, strains from
different origin are capable to provoke necro-hemorrhagic
lesions in an intestinal loop model [10]. It cannot be ruled
out that other possible virulence factors may be involved in
disease. This was the case for necrotic enteritis in broiler
chickens, an enteric disease caused by C. perfringens type
A strains. The essential virulence factor for causing disease
remained unclear until the NetB toxin, a previously un-
known toxin specific for necrotic enteritis, was found [20].
Although the presence of such an undiscovered toxin in
the pathology of bovine enterotoxemia cannot be excluded,
it is unlikely because type A strains originating from bovine
enterotoxemia cases as well as from healthy cattle and
other animal species are capable of inducing lesions in an
intestinal loop model [10].
Conclusions
Strains from bovine enterotoxemia cases did not have
a higher alpha toxin, perfringolysin O, mucinolytic orgelatinolytic activity in comparison to strains isolated from
healthy cattle and other animal species. Also production of
intra-species inhibitory substances was not higher in bo-
vine enterotoxemia strains. This could indicate that yet an-
other, hitherto unknown, C. perfringens virulence factor
might be involved in the pathogenesis of calf enterotox-
emia. Taking these results together with our previous ob-
servations that strains from various origin can induce the
typical lesions in an intestinal loop model [10], it seems
however more plausible that the primary trigger in bovine
enterotoxemia is not C. perfringens and that C. perfringens
is merely responsible for propagating and exacerbating the
intestinal damage to the point that it becomes hemorrhagic
and necrotic.
Methods
Bacterial strains and culture conditions
The 46 C. perfringens strains used in this study are listed
in Table 1. One isolate per animal was used. Eight strains
were isolated from enterotoxemic calves and 23 from
healthy calves. Also five strains from ruminating cattle were
included. In addition five strains isolated from chicken and
five ovine strains were included. This study describes the
in vitro characterization of Clostridium perfringens strains
and thus does not need approval of an ethical committee.
Bacteria were isolated on Columbia agar (Oxoid,
Basingstoke, UK) supplemented with 5% defibrinated
sheep blood, 12 mg/l kanamycin sulphate and 30 000 IU/l
polymixin B sulphate. The toxinotype of the C. perfringens
strains was determined by a multiplex polymerase chain
reaction (PCR), as described by Yoo et al. [23], while the
presence of the enterotoxin, NetB and the consensus and
atypical beta2 toxin genes were detected with previously
described single PCR reactions [20,24,25]. The strains
were cultured anaerobically for 24 h at 37°C in TGY broth
(3% tryptone, 2% yeast extract, 0.1% glucose and
0.1% L-cysteine) for the toxin assays, in BHI broth (VWR,
Leuven, Belgium) supplemented with 0.4% (w/v) glucose
for growth-inhibition assays and measurements of gelati-
nolytic activity and in tryptone soy broth (TSB) (Oxoid)
for quantification of the mucinolytic activity. Cell-free su-
pernatants from the C. perfringens cultures were obtained
by centrifugation followed by filtration of the supernatants
through a 0.2 μm filter and stored at −20°C.
Detection of toxin activity
To determine the alpha toxin activity in the supernatants,
the lecithinase acitivity was assayed in an egg yolk agar well
diffusion assay [26]. Therefore 7 mm diameter holes were
punched out in Columbia agar (Oxoid) supplemented with
2% (vol/vol) egg yolk with the back of a 20-200 μl pipette
tip and 20 μl of the tested supernatants was added to
each hole. Pure alpha toxin (Sigma-Aldrich, St-Louis,
USA) was used as standard. Plates were incubated at 37°C
Table 1 Origins and toxinotypes of C. perfringens strains
Strain Origin Toxin genes Reference
Bovine enterotoxemia
BCP62 BB calf, hemorrhagic gut cpa+ [10]
BCP134 HF calf, hemorrhagic gut cpa+ [10]
BCP256 BB calf, hemorrhagic gut cpa+ [10]
BCP472 BB calf, hemorrhagic gut cpa+ This study
BCP510 BB calf, hemorrhagic gut cpa+ [10]
BCP544 BB calf, hemorrhagic gut cpa+ [10]
BCP588 BB calf, hemorrhagic gut cpa+ This study
BCP730 BB calf, hemorrhagic gut cpa+ This study
Healthy calves
BCP20 HF calf, abomasal ulcer cpa+ [21]
BCP311 BB calf, rectal swab cpa+ This study
BCP334 BB calf, rectal swab cpa+ [10]
BCP447 BB calf, healthy gut cpa+ [10]
BCP506 BB calf, rectal swab cpa+ [10]
BCP513 BB calf, rectal swab cpa+ This study
BCP740 HF calf, healthy gut cpa+ This study
BCP747 BB calf, healthy gut cpa+ This study
BCP795 BB calf, rectal swab cpa+ This study
BCP796 BB calf, rectal swab cpa+ This study
BCP797 HF calf, rectal swab cpa+ This study
BCP799 HF calf, rectal swab cpa+ This study
BCP806 BB calf, rectal swab cpa+ This study
BCP808 BB calf, rectal swab cpa+ This study
BCP812 BB calf, rectal swab cpa+ This study
BCP821 BB calf, rectal swab cpa+ This study
BCP822 HF calf, rectal swab cpa+ This study
BCP823 HF calf, rectal swab cpa+ This study
BCP824 HF calf, rectal swab cpa+ This study
BCP825 HF calf, rectal swab cpa+ This study
BCP828 BB calf, rectal swab cpa+ This study
BCP836 HF calf, rectal swab cpa+ This study
BCP837 HF calf, rectal swab cpa+ This study
Ruminating cattle
BCP783 HF bull, rectal swab cpa+ This study
BCP815 BB cow, rectal swab cpa+ This study
BCP820 BB cow, rectal swab cpa+ This study
L2660 HF cow, rectal swab cpa+ This study
L2664 BB cow cpa+ This study
Sheep
SCP1 Rectal swab cpa+ This study
SCP2 Rectal swab cpa+ This study
SCP3 Rectal swab cpa+ This study
Table 1 Origins and toxinotypes of C. perfringens strains
(Continued)
SCP4 Rectal swab cpa+ This study
SCP5 Rectal swab cpa+ This study
Chicken
CP17 Healthy cpa+ [19]
CP23 Healthy cpa+ netB+ [19]
CP24 Healthy cpa+ [19]
CP56 Necrotic enteritis cpa+ netB+ [19]
NE18 Necrotic enteritis cpa+ netB+ [22]
BB = Belgian Blue, HF = Holstein Friesian.
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tometer (Bio-Rad Laboratories, Hercules, CA). The diame-
ters of the zones of opacity were measured using Quantity
One software (Bio-Rad Laboratories).
Perfringolysin O (PFO) activity in the supernatants was
determined by measuring the hemolysis of horse erythro-
cytes using a doubling dilution assay as previously de-
scribed [11]. The PFO titer is the reciprocal of the last
dilution which showed complete hemolysis. The unit of ac-
tivity was expressed on a logarithmic scale as a log2 value
(titer), and consequently each difference in titer of one unit
represents a twofold difference in perfringolysin O activity.
Both assays were performed in triplicate, with su-
pernatants of two independent biological replicates of
C. perfringens cultures grown in TGY.Detection and measurement of proteolytic activity
To determine the mucinolytic activity of the different
C. perfringens strains, 7 mm diameter holes were punched
out TSA plates supplemented with 0.5% (w/v) type II gas-
tric mucin (Sigma-Aldrich) with the back of a 20-200 μl
pipette tip. Twenty μl of each overnight culture was added
to each hole (3 wells per overnight culture). The plates
were anaerobically incubated for 16 hours at 37°C and
subsequently stained for 30 minutes with amido black
staining solution (Sigma-Aldrich). Plates were destained
with destaining solution (25% isopropanol and 10% acetic
acid) and scanned with a GS-800 calibrated densitometer
(Bio-Rad Laboratories). Lysis of mucin was observed as a
halo of clearing around the wells. The diameters of the
zones of mucin lysis were measured using Quantity One
software (Bio-Rad Laboratories).
Detection of gelatinolytic activity with an EnzChek
Gelatinase/Collagenase Assay kit was carried out according
to the recommendations of the manufacturer (Molecular
Probes). Briefly, filter-sterilized supernatant of BHI over-
night cultures was incubated with 12.5 μg/ml fluorescein-
labeled gelatin substrate for 3 hours at 37°C (2 wells per
overnight culture). Gelatinolytic activity was measured as
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515 nm) by a Fluoroskan Ascent Fluorometer and Lumin-
ometer (Thermo Fisher Scientific Inc., Waltham, USA).
Both assays were performed with two independent bio-
logical replicates of C. perfringens cultures.
In vitro growth-inhibition assay
All 46 C. perfringens strains were used in a checkerboard
test for intra-species growth-inhibition as previously de-
scribed [9]. Each strain was cultured anaerobically in BHI
broth for 24 h at 37°C. The overnight cultures were diluted
1/1000 in 10 ml BHI agar and poured on the whole surface
of BHI agar plates to obtain a bacterial lawn. With a sterile
toothpick each C. perfringens isolate was transferred from
the overnight culture to the agar plates seeded with the
different C. perfringens strains. Absence of growth of the
bacterial lawn around a colony results in an inhibition
zone. After overnight incubation under anaerobic condi-
tions, inhibition was evaluated. The test was performed in
duplicate.
Statistical analysis
All tests were performed in duplicate and data were ana-
lyzed using a Kruskal-Wallis test followed by a Dunn’s mul-
tiple comparison test. Statistical analyses were performed
using GraphPad Prism 5 software.
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